The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Deal to complete by Wed 4th April http://ca.finance.yahoo.com/news/afferro-severstal-announce-delay-closing-180000869.html
http://investegate.co.uk/Article.aspx?id=201102030700095980A Avacta and Cold Spring have entered into an exclusive distribution agreement for the sale of Optim in China, Hong Kong and Taiwan in what the Directors believe is a strategically important market for the Company.
US Product Sale !! http://www.investegate.co.uk/Article.aspx?id=201101040700077795Y
Great Update -NAV 52p per share, £22m cash and ........ From RNS ".....it has been particularly encouraging to note further significant developments in the commercial and technical progress of the Group's portfolio businesses in the third quarter. The announcement of product launches and partnerships with major global companies serves to highlight the significant potential value in these companies' technologies." So, 52p plus further significant developments emerging..........
In 1.05-1.07p. Maybe the news of the one sale of the Optim to the world's largest Biopharmaceutical developer earlier this week has resulted in more orders for the Optim. Not without risks here, but this company has under achieved on sales of its technology over the years. Perhaps it is now turning the corner!
Just rechecked, the NAV at the end of June is actually £149m (compared with a market cap of £77m), if we exclude goodwill (£167.4m-£18.4m), and includes £24m cash. If we add to that the 'hope' value attached to the companies where its products could soon be maturing in their markets eg MWG, PRX, Rev7, AVCT, ......then it's not beyond the realms that this could double in the next 6-12 months. But settling for a reversal initially, followed by 30-40% would be a good start!!
Thanks for your post. Nice to see Numis or any broker catching up ! lol ! No, I can't see this being a multibagger, but it's ripe for 30-40% I think. There is such a mass of positive information out there on it. Today for example....the increase in Avacta (AVCT) price added almost £0.5 mill on Market Cap. Incidentally AVCT had a very solid day today, they have underperformed form many months, could be worth watching tomorrow. Late reported buy of 5m shares. Earlier in the week it was their investment in PRX in the limelight and Revolymer before that. Directors Buys not to far back July I think. All good, just needs to bounce!!
Recent results If you read the results in detail you will find part way through a list of the quoted companies and unquoted companies. http://www.iii.co.uk/investment/detail?code=cotn:IPO.L&display=news&it=le
Here's some of the detailed news released recently which may help..... 17.9% stake in AVACTA (AVCT) New sales order from world's largest biopharmaceutical developer announced today http://www.investegate.co.uk/Article.aspx?id=201010270700050557V 23.2% stake in Modern Water (MWG) Interim results 15/9/10 http://www.investegate.co.uk/Article.aspx?id=201009150700076900S 8.2 % stake in Proximagen (PRX) Pharmaceutical giant increased holdings yesterday http://www.investegate.co.uk/Article.aspx?id=201010260700079811U Director share purchase last week in PRX http://www.investegate.co.uk/Article.aspx?id=201010210700107445U Rev7 Revolymer non-stick chewing gum competing with Wrigleys http://blogs.forbes.com/parmyolson/2010/10/05/non-stick-gum-tries-to-chew-up-the-market/ The potential for many of these companies is significant. This is just a selection, there is a lot of more information out there of the quoted companies that IPO is invested in. See the list on the attached 6 month results.